COLLNasdaq United States
Market cap
$955.823 M
$29.47 +1.24%
Close of 7 Aug 2026
Revenue
$780.6M
#1671 by revenue
Earnings
$63.0M
#1488 by earnings
Shares outstanding
32,555,613
Latest filing cover page
P/E ratio
15.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Collegium Pharmaceutical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.